ViewRay, Inc. (VRAYQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jul 31, 2025, 10:34 AM EDT
Triumph Group Market Cap
ViewRay has a market cap or net worth of $183.00 as of August 1, 2025. Its market cap has decreased by -99.00% in one year.
Market Cap
183.00
Enterprise Value
n/a
Revenue
105.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 10, 2015, ViewRay's market cap has decreased from 188.28M to 183.00, a decrease of -100.00%. That is a compound annual growth rate of -75.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 183.00 | - |
| Dec 31, 2024 | 183.00 | - |
| Dec 29, 2023 | 183.00 | -100.00% |
| Dec 30, 2022 | 812.74M | -16.61% |
| Dec 31, 2021 | 974.62M | 71.81% |
| Dec 31, 2020 | 567.27M | -4.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |